Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06087224 · ClinicalTrials.gov registry record · NA
The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals
A NA study of Death; Neonatal and Morbidity;Newborn, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 947
- Enrollment target
- 20
- Study locations
NCT06087224: Recruiting NA study of Death; Neonatal and Morbidity;Newborn, sponsored by Mayo Clinic.
NCT06087224 is a NA study of Death; Neonatal and Morbidity;Newborn that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 947 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (33% lower). The trial reports 20 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06087224, a NA study of Death; Neonatal and Morbidity;Newborn, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 947 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to evaluate the impact of real-time audio-video telemedicine consults with a neonatologist (termed teleneonatology) on the early health outcomes of at-risk neonates delivered in community hospitals.
Primary Outcome
Percentage of neonates classified as dying within 7 days, defined as death on or before 23:59 on the seventh completed day of life.
Conditions Studied
Interventions
- OTHER Teleneonatology
Study Locations (20)
Washington
- Island Health - Anacortes
- Providence Regional Medical Center Everett - Everett
- Olympic Medical Center - Port Angeles
- Seattle Children's Hospital - Seattle
- University of Washington - Seattle
- Central Washington Health Services Association d/b/a Confluence Health - Wenatchee
Wisconsin
- Prairie Ridge Health - Columbus
- Fort HealthCare - Fort Atkinson
- University of Wisconsin-Madison - Madison
- Sauk Prairie Healthcare - Prairie du Sac
- Reedsburg Area Medical Center - Reedsburg
Oklahoma
- Chickasaw Nation Medical Center - Ada
- Jackson County Memorial Hospital - Altus
- Great Plains Regional Medical Center - Elk City
- University of Oklahoma Health Sciences Center - Oklahoma City
Alaska
- Providence Alaska Medical Center - Anchorage
- Bartlett Regional Hospital - Juneau
- PeaceHealth Ketchikan Medical Center - Ketchikan
Arizona
- Mayo Clinic Arizona - Pheonix
Minnesota
- Mayo Clinic Minnesota - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 947 participants |
| Start Date | 2024-03-05 |
| Est. Completion | 2029-05-01 |
| Phase | NA |
What NCT06087224 shows while recruiting
NCT06087224 is an interventional study that assigns participants to a tested intervention. The registered 947 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (33% lower).
The record links to 2 conditions, with Death; Neonatal appearing as the primary indexed condition, and to 1 intervention - of which Teleneonatology is the first listed.
NCT06087224 names 20 study sites across 6 states, led by Washington, Wisconsin, Oklahoma.
Frequently Asked Questions
What is clinical trial NCT06087224 about?
NCT06087224 is a clinical study titled "The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals". The purpose of this study is to evaluate the impact of real-time audio-video telemedicine consults with a neonatologist (termed teleneonatology) on the early health outcomes of at-risk neonates delivered in community hospitals.
What is the current status of trial NCT06087224?
This trial is currently recruiting. It is a NA study. The enrollment target is 947 participants. The study started on 2024-03-05. Estimated completion is 2029-05-01.
What conditions does trial NCT06087224 study?
This clinical trial studies the following conditions: Death; Neonatal, Morbidity;Newborn.
What interventions are being tested in trial NCT06087224?
The interventions under investigation include: Teleneonatology (OTHER).
Who is sponsoring clinical trial NCT06087224?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06087224 being conducted?
This trial has 20 study locations across Alaska, Arizona, Minnesota, Oklahoma, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Death; Neonatal
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06087224's enrollment target sits among peer trials
947 123rd of 2000 higher than 1,878 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04895709 · 949 participants · Phase 1
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
- NCT03784924 · 950 participants
EDRN Prostate MRI Biomarker Study
- NCT04180930 · 950 participants
An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran Sample
- NCT05020236 · 944 participants · Phase 3
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI